WHC is still in active development. Read this to understand our approach.
depiction of XPSQPHWEGNHMSK-UHFFFAOYSA-N.svg
isomerdesign

Frovatriptan

Check on isomerdesign

pubchem

Frovatriptan

Check on pubchem

drugmap

Frovatriptan

Check on drugmap

wiki

Frovatriptan

Check on wiki

Data

InChI: InChI=1S/C14H17N3O/c1-16-9-3-5-13-11(7-9)10-6-8(14(15)18)2-4-12(10)17-13/h2,4,6,9,16-17H,3,5,7H2,1H3,(H2,15,18)

Synonyms: R-Frovatriptan,FROVATRIPTAN [MI], SB-209509,Frovatriptan (INN), Auradol,Allergo filmtabletten (TN), Frovatriptan (INN),1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (3R)-,ZINC18635,NCGC00408835-01, Miguard,SCHEMBL34410,FROVATRIPTAN [INN], Allergo filmtabletten(TN), (R)-5,6,7,8-Tetrahydro-6-(methylamino)carbazole-3-carboxamide,VML-251, (6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide,BIDD:PXR0142,HY-B1658,CS-0013614,SB 209509,(R)-5,6,7,8-Tetrahydro-6-(methylamino)carbazole-3-carboxamide, Allergo filmtabletten,1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (R)-, Rilamig, SB 209509,Rilamig,GTPL7191,SB-209509,FROVATRIPTAN [VANDF],FROVATRIPTAN [HSDB],158747-02-5,D07997,FROVATRIPTAN [MART.],Frovatriptan,(3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide, Frova (TN), (3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide,SB209509, Frovelan,(R)-6-Methylamino-6,7,8,9-tetrahydro-5H-carbazole-3-carboxylic acid amide,UNII-H82Q2D5WA7,H82Q2D5WA7, Frova,Frova,(6R)-6-(methylamino)-6,7,8,9-tetrahydro-5H-carbazole-3-carboxamide,Frovatriptan [INN:BAN],EN300-24114152,Q410195,HSDB 7363,DTXSID0023080,(3R)-3-(methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboximidic acid,DB00998,Allergo filmtabletten,CHEBI:134991,Auradol,CHEMBL1279,Allegro,FROVATRIPTAN [WHO-DD], Migard,BDBM50073689

Estimated data

Solubility: -2.183 (log(S) in mol/L prediction using SolTranNet)

Blood Brain Barrier Permeability: No (prediction using frontiersin.org)

Addictivity Prediction: 40.0% (prediction based on www.mdpi.com)

Similarities

The following is a set of comparisons to understand the properties of this compound. This is still higly experimental and is still under active development. Please refer to our series of blog posts to fully understand our approach and its limitations. This information is for informational purposes only and should not be construed as medical advice.